Tumor estromal gastrointestinal del intestino delgado con expresión negativa del marcador oncogénico KIT (CD117): A propósito de un caso
Resumen
Texto completo:
PDFReferencias
Sandrasegaran K, et al. Gastrointestinal stromal tumors: clinical,radiologic and pathologic features. AJR 2005; 184:803. [ Links ]
D´Amato G, et al. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 2005; 12:44-56. [ Links ]
Nickl N. Gastrointestinal stromal tumors: new progress,new questions. Current opinion in Gastroenterology, 2004; 20:482-487. [ Links ]
Medeiros F, et al. Kit negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications. Am J Surg Pathol 2004; 28:889-894. [ Links ]
Heinrich MC, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299:708-710. [ Links ]
Hirota S. Review of pathophysiology on GIST: the role of inmunohistochemical staining and ckit mutational analysis. 6th International Gastric Cancer Congress. Yokohama Japan. Current status of the management of GIST. 2005 May 6, Symposium S9-2:4. [ Links ]
Chandu de Silva MV. Gastrointestinal stromal tumors(GIST). Orphanet encyclopedia 2005; Feb:1-6. [ Links ]
Xiu YS, et al. Gastrointestinal tumors: update. Arkh Patol 2004; 66:36-40. [ Links ]
De Mestier P. Treatment of gastrointestinal stromal tumors with Imatinib Mesylate: a major breakthrough in the understanding of tumor specific molecular characteristics. World J Surg 2005; Feb 10. [ Links ]
DOI: http://dx.doi.org/10.61155/gen.v60i3.774
VIDEOS GEN
Autor: Dr. Juan Carlos González
![]() |
![]() | ![]() | ![]() |
ISSN: 0016-3503 e-ISSN: 2477-975X